Results 271 to 280 of about 12,784,255 (313)
Some of the next articles are maybe not open access.

Targets for therapy in ependymoma

Targeted Oncology, 2011
Ependymomas are among the rarest type of glioma and display significant heterogeneity based on patient age and tumor location. Treatment strategies include surgery and radiation, but the use of chemotherapy remains more controversial. Chemotherapy has been widely utilized in the pediatric population due to more aggressive disease in this cohort, and ...
openaire   +2 more sources

Target Therapy in SLE

Autoimmunity Reviews, 2019
The intention of this paper is to review actual developments in target therapy in SLE. Target therapy includes both the objective of intervention and the aim of treatment. The objective should be linked to the pathophysiologic process of SLE; the aim has to be in any case an improved outcome. The current therapeutic in SLE is guided mostly by secondary
openaire   +2 more sources

Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm

Nature Reviews Clinical Oncology, 2021
Yoshiaki Nakamura   +4 more
semanticscholar   +1 more source

Targeting complement in therapy

Immunological Reviews, 2001
Summary:With increasing evidence that complement activation significantly contributes to the pathogenesis of a large number of inflammatory diseases, strategies that interfere with its deleterious action have become a major focus in pharmacological research. Endogenous soluble complement inhibitors (C1 inhibitor, recombinant soluble complement receptor
openaire   +2 more sources

Targeted Therapy

Der Hautarzt, 2008
J C, Becker, M, Hertl
openaire   +2 more sources

Targeted Therapies for Melanoma

2015
Since the discovery of activating mutations in the BRAF oncogene and also stimulation of immune mediated antitumor response in melanoma, there has been remarkable progress in the development of targeted therapies for unresectable and metastatic melanoma. This article addresses the latest developments of BRAF/MEK/ERK pathway signaling.
U, Leiter, F, Meier, C, Garbe
openaire   +2 more sources

Targets of therapy for NIDDM

Diabetes Research and Clinical Practice, 1995
Non-insulin-dependent diabetes (NIDDM) is a common multimetabolic disorder with potential (and potentially severe) long-term complications affecting large and small blood vessels. Where microvascular complications (retinopathy, nephropathy and neuropathy) are concerned, the Diabetes Control and Complications Trial (DCCT), as well as much circumstantial
openaire   +2 more sources

Rational combinations of targeted cancer therapies: background, advances and challenges

Nature reviews. Drug discovery, 2022
Hao-Jie Jin, Liqin Wang, R. Bernards
semanticscholar   +1 more source

The Broadening Scope of Oral Mucositis and Oral Ulcerative Mucosal Toxicities of Anticancer Therapies

Ca-A Cancer Journal for Clinicians, 2022
Stephen Sonis   +2 more
exaly  

Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases

Nature Reviews Rheumatology, 2022
B. Soós   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy